🔴 Tenax Therapeutics is trading 5% down with no clear catalyst identified

Tenax Therapeutics is trading at $1.63, down 5.23% on October 26, 2026, with no clear new company announcement explaining the decline.

• Recent coverage described cautious analyst reassessments after the Phase 3 LEVEL trial missed its primary endpoint, but did not establish those developments as the direct cause.
• The broader market was higher, so the decline did not appear to reflect market direction.
• Volume or other activity-level confirmation was unavailable from the provided live price context.